Key Account Manager- RB - Immunology - Chennai
Johnson & Johnson (company site, opens in a new tab)ChennaiOn-siteDirect career pageEst. 12–22 LPA
Posted 3d ago
Reach people at Johnson & Johnson
People at this company you can reach
Log in to see who works here
Create a free account or log in to see the people at Johnson & Johnson you could write to:
- Recruiters & HR
- People in this function
- Work addresses
Your match
Against your primary resume
Log in to see your match score
Create a free account or log in to unlock your CV match score across:
- Role fit
- Experience
- Industry relevance
Protocol Intelligence
How competitive this role is
Competition
Background fit
Strictness
Log in to see why each signal reads the way it does.
Job description
Structured overview of role & requirements
About This Role
- Own and achieve reimbursed sales targets for Tremfya franchise (PSO, PsA, IBD) across government/institutional accounts including Army, CGHS, Railways, ESI, States, Autonomous institutes, and PSU.
- Develop detailed 360° launch account plans, map patient pools, treating specialists, access status, and facilitate access through government schemes and tenders.
- Engage KOLs, navigate reimbursement pathways, coordinate cross-functionally with Medical, Franchise, and Value teams, ensuring compliance and ethical engagement.
Minimum Requirements
- Experience Required: Not explicitly mentioned in the JD
- Must have knowledge and experience in pharmaceutical sales especially immunology and biologics.
- Location: Chennai, Tamil Nadu, India (Onsite implied)
- Mandatory skills include strategic account management, commercial selling, access & reimbursement navigation, and compliance adherence.
Ideal Candidate Profile
- Demonstrated ability in managing complex government and institutional pharmaceutical accounts with a focus on reimbursed biologic products.
- Experienced in navigating multiple stakeholder environments including KOLs, government authorities, and cross-functional internal teams.
- Proven skills in strategic launch planning, demand forecasting, tender management, and growing biologic franchise share in institutional segments.